One Health Biosensing

20 Days left to invest in One Health Biosensing's Community Round!

Jeff Dachis

Published on Apr 11

One Health Biosensing
One Health CGM - AI Enabled, pain-free, needle-free, and ultra low cost


The opportunity to invest in One Health Biosensing's community round is coming to a close at the end of this month. Invest now or increase your investment here: https://wefunder.com/onehealthbiosensing

We've been overwhelmed by the positive support received from our community of people passionate about transforming the lives of every single person on the planet with diabetes.

However, in an International Diabetes Federation event this past week it was estimated that in 2024, 589 million people (1 in 9) on the planet have diabetes. It was estimated that the cost of treating these people in 2024 exceeded $1 trillion USD representing 12% of all global health expenditures. It is estimated that this population and the cost to treat them will grow almost 50% to 850 million people and $2 trillion USD.

This is alarming.

CGM has proven to be one of the most effective and powerful tools in the arsenal for people to manage, treat, and reverse their diabetes, but less than 5% of people with diabetes have access to CGM. One Health Biosensing's next generation AI-enabled CGM offers people an ultra-low cost option, flexible dosing, pain-free needle-free experience, and multi-analyte, multi-modal sensing capabilities, and a consumer grade user experience designed from the ground up to meet the needs of a data-driven health environment now and in the future.

The time is now and we need your help to finalize our in clinic efforts and get One Health through the FDA and into market over the next several months. please invest now or increase your investment here: https://wefunder.com/onehealthbiosensing and join our community.

More to come and thank you,



Jeff Dachis - CEO - One Health Biosensing Inc.




Awesome